We will start off by providing an explanation on a nine-month basis. Net sales in the Business Technologies Business increased 1% year on year to 4.3 billion yen. Because the yen was high against the euro on a nine-month basis, this represents a sales increase of approximately 3% on a local currency basis excluding the impact of exchange rates. For the third quarter, net sales were up by 8.3 billion yen. While the sales growth rate was 6%, the sales growth rate would only be approximately 3% if the impact of exchange rates is excluded.
Net sales in the Industrial Business increased by 16% on a nine-month basis. For the third quarter, net sales increased by 15%. Main products such as TAC films supported the increase in sales.
Net sales of the Healthcare Business were down year on year on both a nine-month basis and for the third quarter. The main cause for this decrease was the decrease in sales of film products. However, sales of digital equipment have grown steadily.
Next, we will provide an explanation on operating income. In the Business Technologies Business, operating income was down year on year on both a nine-month basis and for the third quarter. We recognize this position as slightly weak compared to the plan.
Meanwhile, profits doubled in the Industrial Business on both a nine-month basis and for the third quarter.
In the Healthcare Business, profits were 1.2 billion yen on a nine-month basis. While "0" is displayed as profits for the third quarter, a small profit of 20 million yen was actually achieved. While the Group continued to record an operating loss in this business, sales of digital products increased and we believe that the results of business earnings reforms are beginning to become apparent.
In summary of the above, for the Business Technologies Business sales increased while profits decreased, for the Industrial Business both sales and profits increased, and for the Healthcare Business sales decreased and profits increased. This reflects the same trend of earnings on both a nine-month basis and for the third quarter.
Net sales in the Industrial Business increased by 16% on a nine-month basis. For the third quarter, net sales increased by 15%. Main products such as TAC films supported the increase in sales.
Net sales of the Healthcare Business were down year on year on both a nine-month basis and for the third quarter. The main cause for this decrease was the decrease in sales of film products. However, sales of digital equipment have grown steadily.
Next, we will provide an explanation on operating income. In the Business Technologies Business, operating income was down year on year on both a nine-month basis and for the third quarter. We recognize this position as slightly weak compared to the plan.
Meanwhile, profits doubled in the Industrial Business on both a nine-month basis and for the third quarter.
In the Healthcare Business, profits were 1.2 billion yen on a nine-month basis. While "0" is displayed as profits for the third quarter, a small profit of 20 million yen was actually achieved. While the Group continued to record an operating loss in this business, sales of digital products increased and we believe that the results of business earnings reforms are beginning to become apparent.
In summary of the above, for the Business Technologies Business sales increased while profits decreased, for the Industrial Business both sales and profits increased, and for the Healthcare Business sales decreased and profits increased. This reflects the same trend of earnings on both a nine-month basis and for the third quarter.